← Back to Search

Behavioral Intervention

CHW Support for Quitting Smoking During Pregnancy (SFHOPE Trial)

N/A
Recruiting
Led By Anne Berit Petersen, PhD
Research Sponsored by Loma Linda University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age > 18 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline; during the intervention; through study completion, an average of 10 months.
Awards & highlights
No Placebo-Only Group

Summary

"This trial is creating a new program to help pregnant women in San Bernardino County quit smoking."

Who is the study for?
This trial is for pregnant smokers in San Bernardino County who are interested in quitting smoking. Specific eligibility criteria have not been provided, but typically participants would need to be of legal age for consent and willing to follow the study procedures.
What is being tested?
The trial is testing a new behavioral tobacco cessation program designed specifically for pregnant women. Participants will either receive this specialized support from community health workers integrated into their prenatal care or be placed in a control group without this additional intervention.
What are the potential side effects?
Since the intervention involves behavioral support rather than medication, there may not be direct side effects like with drugs; however, stress or anxiety related to quitting smoking could potentially occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 18 years.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline; during the intervention; through study completion, an average of 10 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline; during the intervention; through study completion, an average of 10 months. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Self-Report Tobacco Abstinence
Secondary study objectives
Arm 1 Satisfaction with CHW visit
Carbon Monoxide Level

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Integrated HCP-CHW Intervention ArmExperimental Treatment1 Intervention
CHW visit with brief tobacco cessation intervention.
Group II: Control armExperimental Treatment1 Intervention
Standard of Care

Find a Location

Who is running the clinical trial?

Riverside University Health System Medical CenterOTHER
5 Previous Clinical Trials
1,712 Total Patients Enrolled
University of California, San FranciscoOTHER
2,593 Previous Clinical Trials
14,887,875 Total Patients Enrolled
12 Trials studying Tobacco Use
1,700 Patients Enrolled for Tobacco Use
Loma Linda UniversityLead Sponsor
316 Previous Clinical Trials
266,570 Total Patients Enrolled
Anne Berit Petersen, PhDPrincipal InvestigatorLoma Linda University
~38 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top